Integrated physiology and pathophysiology of CB1-mediated effects of the endocannabinoid system
- 1 April 2007
- journal article
- review article
- Published by Elsevier in Diabetes & Metabolism
- Vol. 33 (2) , 97-107
- https://doi.org/10.1016/j.diabet.2007.02.002
Abstract
No abstract availableKeywords
This publication has 137 references indexed in Scilit:
- Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lepob/Lepob miceInternational Journal of Obesity, 2004
- Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the ratPhysiology & Behavior, 2004
- Efficacy in CB1 receptor-mediated signal transductionBritish Journal of Pharmacology, 2004
- Obesity Wars: Molecular Progress Confronts an Expanding EpidemicPublished by Elsevier ,2004
- Activation of the Cannabinoid Receptor Type 1 Decreases Glutamatergic and GABAergic Synaptic Transmission in the Lateral Amygdala of the MouseLearning & Memory, 2003
- Endogenous cannabinoid system as a modulator of food intakeInternational Journal of Obesity, 2003
- SHORT COMMUNICATION Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoidsEuropean Journal of Neuroscience, 2002
- The endocannabinoid system in invertebratesProstaglandins, Leukotrienes & Essential Fatty Acids, 2002
- Increase in meso‐prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoidsEuropean Journal of Neuroscience, 1998
- Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brainBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995